Abstract
Aims: Post-operative pain following cardiac implantable electronic device (CIED) insertion is associated with patient dissatisfaction, emotional distress, and emergency department visits. We sought to identify factors associated with post-operative pain and develop a prediction score for post-operative pain. Methods and results: All patients from the BRUISE CONTROL-1 and 2 trials were included in this analysis. A validated Visual Analogue Scale (VAS) was used to assess the severity of pain related to CIED implant procedures. Patients were asked to grade the most severe post-operative pain, average post-operative pain, and pain on the day of the first post-operative clinic. Multivariable regression analyses were performed to identify predictors of significant post-operative pain and to develop a pain-prediction score. A total of 1308 patients were included. Multivariable regression analysis found that the presence of post-operative clinically significant haematoma {CSH; P value < 0.001; odds ratio (OR) 3.82 [95% confidence interval (CI): 2.37-6.16]}, de novo CIED implantation [P value < 0.001; OR 1.90 (95% CI: 1.47-2.46)], female sex [P value < 0.001; OR 1.61 (95% CI: 1.22-2.12)], younger age [<65 years; P value < 0.001; OR 1.54 (95% CI: 1.14-2.10)], and lower body mass index [<20 kg/m2; P value < 0.05; OR 2.05 (95% CI: 0.98-4.28)] demonstrated strong and independent associations with increased post-operative pain. An 11-point post-operative pain prediction score was developed using the data. Conclusion: Our study has identified multiple predictors of post-operative pain after CIED insertion. We have developed a prediction score for post-operative pain that can be used to identify individuals at risk of experiencing significant post-operative pain.
Original language | English |
---|---|
Pages (from-to) | 748-756 |
Number of pages | 9 |
Journal | Europace |
Volume | 23 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 1 2021 |
Externally published | Yes |
Bibliographical note
Funding Information:Bruise CONTROL-1 was supported by an operating grant from the Canadian Institutes of Health Research (CIHR), a CIHR Clinician Scientist Award (V.E.), and an Innovations grant from the University of Ottawa Heart Institute Academic Medical Organization Alternate Funding Program (funded by the Ministry of Health of Ontario). Bruise CONTROL-2 was supported by a grant from the Heart and Stroke Foundation of Canada (grant number G-14-0005725), a Fonds de recherche du Quebec-Sante (FRQS) Clinical Research Scholar Award (V.E.) and grants from Boehringer Ingelheim, Germany; Bayer HealthCare AG, Leverkusen, Germany; Pfizer and Bristol-Myers Squibb, New York, NY, USA.
Publisher Copyright:
© 2020 Published on behalf of the European Society of Cardiology. All rights reserved.
ASJC Scopus Subject Areas
- Cardiology and Cardiovascular Medicine
- Physiology (medical)
PubMed: MeSH publication types
- Journal Article